Shenzhen Kangzhe Biotechnology Co., Ltd.

This early-stage study tests a new drug, CMS-D008, in healthy and overweight adults to see if it is safe and how the body processes it. About 110 participants will receive either the drug or a placebo through injections. The goal is to gather initial safety data, not to prove wei…